Tuesday, December 9, 2014
Bellicum Pharmaceuticals Sets IPO Pricing Range
Houston-based Bellicum Pharmaceuticals has moved one step closer to its IPO, saying today in a regulatory filing that it now expects its initial IPO pricing range to be between $15.00 and $17.00 per share. The company hoping to sell 6,250,000 shares of its common stock in its offering. Bellicum is looking to list on the NASDAQ Global Market as BLCM. The company is in the midst of developing cellular immunotherapies for various forms of cancer. The company is venture backed by Baker Brothers Life Sciences, Remeditex Ventures, AG Ventures, RA Capital Management, and others.